HYALURONATE SODIUM

HYALURONATE SODIUM was reported 1534 times

HYALURONATE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMA SITE DERMATITIS 12 0.3636
1 TYMPANOMETRY ABNORMAL 2 0.3333
2 ACQUIRED HYPOCALCIURIC HYPERCALCAEMIA 1 0.2500
3 CORNEAL EPITHELIAL WRINKLING 2 0.2000
4 OBSTRUCTIVE DEFAECATION 12 0.1791
5 SENSITISATION 115 0.1515
6 EJECTION FRACTION 87 0.1497
7 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 12 0.0828
8 DIFFUSION-WEIGHTED BRAIN MRI ABNORMAL 2 0.0741
9 POLYCYSTIC OVARIES 112 0.0722
10 EJECTION FRACTION ABNORMAL 70 0.0571
11 CONJUNCTIVAL SCAR 8 0.0530
12 OCULAR PEMPHIGOID 6 0.0480
13 SARS-COV-2 TEST FALSE POSITIVE 2 0.0455
14 PROPULSIVE GAIT 2 0.0444
15 NAIL BED INFLAMMATION 13 0.0408
16 AQUEOUS FIBRIN 2 0.0392
17 OBSTRUCTIVE SLEEP APNOEA SYNDROME 56 0.0384
18 NEPHRECTOMY 55 0.0370
19 CORNEAL PIGMENTATION 2 0.0351
20 TOXIC ANTERIOR SEGMENT SYNDROME 37 0.0339
21 CORNEAL THICKENING 2 0.0294
22 RHINITIS ALLERGIC 116 0.0260
23 POLYCYSTIC OVARIAN SYNDROME 10 0.0260
24 VASCULAR ACCESS SITE PAIN 3 0.0250
25 BURKHOLDERIA INFECTION 2 0.0241
26 SYMBLEPHARON 6 0.0230
27 EYE OPACITY 2 0.0217
28 NASAL MUCOSAL DISORDER 12 0.0206
29 CORNEAL EXFOLIATION 2 0.0196
30 STOMA SITE INFLAMMATION 12 0.0161
31 PARANEOPLASTIC NEUROLOGICAL SYNDROME 2 0.0156
32 ADRENAL GLAND CANCER METASTATIC 1 0.0147
33 GRIP STRENGTH 3 0.0131
34 PRESBYACUSIS 4 0.0130
35 CYCLOTHYMIC DISORDER 2 0.0122
36 SWOLLEN JOINT COUNT 3 0.0120
37 LICHEN SCLEROSUS 8 0.0117
38 ARTERIAL INSUFFICIENCY 2 0.0108
39 TRANSIENT ACANTHOLYTIC DERMATOSIS 3 0.0102
40 STREPTOCOCCAL SEPSIS 12 0.0101
41 BRAIN COMPRESSION 4 0.0100
42 IRIS ATROPHY 2 0.0097
43 VITAMIN B1 DEFICIENCY 4 0.0094
44 VESTIBULAR NEURONITIS 5 0.0094
45 GINGIVAL DISCOLOURATION 5 0.0093
46 CORNEAL EROSION 5 0.0093
47 PARANASAL SINUS INFLAMMATION 2 0.0090
48 CORNEAL OPACITY 12 0.0088
49 GRAFT VERSUS HOST DISEASE IN LUNG 4 0.0084
50 CARPAL TUNNEL SYNDROME 117 0.0083
51 TINEA VERSICOLOUR 3 0.0083
52 ACHROMOBACTER INFECTION 1 0.0083
53 BLOOD TEST ABNORMAL 116 0.0082
54 STOMA SITE PAIN 12 0.0082
55 VITAMIN B6 DEFICIENCY 2 0.0081
56 SELF-CONSCIOUSNESS 2 0.0079
57 ANTERIOR CHAMBER FIBRIN 1 0.0078
58 GASTROINTESTINAL STOMA COMPLICATION 12 0.0076
59 ORAL MUCOSAL DISCOLOURATION 5 0.0075
60 HUMIDITY INTOLERANCE 3 0.0075
61 RETINOGRAM ABNORMAL 2 0.0075
62 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 118 0.0069
63 PSEUDOMONAL SEPSIS 12 0.0068
64 CORNEAL INFILTRATES 2 0.0064
65 CORNEAL PERFORATION 4 0.0063
66 PRODUCT CONFUSION 5 0.0063
67 ADENOCARCINOMA OF THE CERVIX 1 0.0062
68 FULL BLOOD COUNT ABNORMAL 65 0.0061
69 UNDERWEIGHT 12 0.0061
70 SLEEP APNOEA SYNDROME 114 0.0060
71 DENTAL DISCOMFORT 5 0.0060
72 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 38 0.0058
73 POSTERIOR CAPSULE OPACIFICATION 2 0.0058
74 HYPERTROPHY 3 0.0055
75 INTERTRIGO 3 0.0055
76 DIVERTICULITIS INTESTINAL HAEMORRHAGIC 2 0.0052
77 ANTIPHOSPHOLIPID ANTIBODIES 1 0.0051
78 ADMINISTRATION RELATED REACTION 1 0.0051
79 KERATOPATHY 8 0.0051
80 PERSISTENT DEPRESSIVE DISORDER 2 0.0050
81 FIBROMYALGIA 120 0.0049
82 TERMINAL ILEITIS 3 0.0049
83 PLASMACYTOMA 9 0.0048
84 CONJUNCTIVAL HYPERAEMIA 17 0.0048
85 NEPHROPATHY 41 0.0044
86 OPHTHALMIC MIGRAINE 3 0.0043
87 KERATITIS 13 0.0043
88 DYSLALIA 3 0.0041
89 HYPOTHYROIDISM 132 0.0041
90 CORNEAL SCAR 2 0.0040
91 RETINAL INJURY 3 0.0039
92 AORTIC DISORDER 3 0.0038
93 VERTEBRAL FORAMINAL STENOSIS 3 0.0036
94 VITREOUS OPACITIES 3 0.0036
95 VASCULAR DEVICE INFECTION 16 0.0035
96 VERTIGO POSITIONAL 6 0.0034
97 AMBLYOPIA 2 0.0034
98 DYSMETRIA 2 0.0033
99 AGE-RELATED MACULAR DEGENERATION 5 0.0033
100 OPEN ANGLE GLAUCOMA 2 0.0033
101 C-REACTIVE PROTEIN 3 0.0032
102 NEURITIS 5 0.0032
103 PARKINSONIAN GAIT 2 0.0032
104 CORNEAL DISORDER 7 0.0032
105 NECROTISING RETINITIS 2 0.0031
106 CORNEAL OEDEMA 7 0.0031
107 CHALAZION 2 0.0031
108 OCULAR HYPERTENSION 6 0.0031
109 FAECES HARD 12 0.0031
110 SMALL INTESTINE ULCER 2 0.0031
111 POST PROCEDURAL SEPSIS 2 0.0030
112 NEUROMYELITIS OPTICA SPECTRUM DISORDER 4 0.0030
113 HEAT ILLNESS 2 0.0030
114 ACQUIRED OESOPHAGEAL WEB 1 0.0029
115 CORNEAL ABRASION 4 0.0029
116 FULMINANT TYPE 1 DIABETES MELLITUS 3 0.0029
117 ACUTE DISSEMINATED ENCEPHALOMYELITIS 1 0.0029
118 PRODUCT EXPIRATION DATE ISSUE 4 0.0029
119 LUMBAR VERTEBRAL FRACTURE 13 0.0028
120 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
121 PORPHYRIA ACUTE 4 0.0028
122 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
123 PARONYCHIA 12 0.0027
124 B-CELL TYPE ACUTE LEUKAEMIA 2 0.0027
125 STRABISMUS 8 0.0027
126 PHYSICAL DECONDITIONING 7 0.0027
127 TINEA INFECTION 3 0.0027
128 ANXIETY DISORDER 9 0.0027
129 PULMONARY SARCOIDOSIS 3 0.0027
130 DYSLEXIA 3 0.0026
131 CHRONIC SPONTANEOUS URTICARIA 3 0.0026
132 INFUSION SITE PRURITUS 8 0.0025
133 CELL DEATH 5 0.0025
134 BREAST CALCIFICATIONS 2 0.0025
135 PLASMA CELL MYELOMA RECURRENT 8 0.0025
136 COMPRESSION FRACTURE 13 0.0024
137 RENAL DISORDER 112 0.0024
138 LUPUS VULGARIS 3 0.0024
139 RETINITIS 4 0.0023
140 ANAEMIA MEGALOBLASTIC 1 0.0022
141 X-RAY ABNORMAL 4 0.0022
142 PLEUROTHOTONUS 2 0.0022
143 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 105 0.0022
144 PUNCTATE KERATITIS 2 0.0022
145 ABULIA 2 0.0022
146 BLADDER SPASM 4 0.0021
147 VARICOSE VEIN 11 0.0021
148 PELVIC DISCOMFORT 2 0.0021
149 PYELOCALIECTASIS 2 0.0021
150 LACUNAR INFARCTION 5 0.0021
151 RETINAL VEIN OCCLUSION 6 0.0021
152 METASTASES TO LYMPH NODES 14 0.0021
153 SPUTUM RETENTION 2 0.0020
154 DEEP VEIN THROMBOSIS POSTOPERATIVE 4 0.0020
155 IMMUNE-MEDIATED DERMATITIS 2 0.0020
156 STOMA SITE HAEMORRHAGE 3 0.0019
157 ASTERIXIS 2 0.0019
158 BURNING SENSATION 125 0.0018
159 MYOCARDIAL INJURY 2 0.0018
160 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 122 0.0017
161 PERIPHERAL VENOUS DISEASE 7 0.0017
162 DEFAECATION URGENCY 12 0.0017
163 ALVEOLAR PROTEINOSIS 1 0.0017
164 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
165 UPPER RESPIRATORY TRACT INFLAMMATION 2 0.0017
166 EYE OEDEMA 4 0.0016
167 POST-ACUTE COVID-19 SYNDROME 2 0.0016
168 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
169 GASTROOESOPHAGEAL REFLUX DISEASE 129 0.0016
170 PROTEIN TOTAL DECREASED 6 0.0016
171 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
172 WHEEZING 94 0.0016
173 GINGIVAL SWELLING 7 0.0016
174 HICCUPS 13 0.0016
175 EYE INFLAMMATION 15 0.0016
176 SWOLLEN JOINT COUNT INCREASED 5 0.0016
177 GINGIVAL RECESSION 3 0.0016
178 FACET JOINT SYNDROME 5 0.0015
179 ENCEPHALITIS AUTOIMMUNE 2 0.0015
180 TUMOUR PAIN 2 0.0015
181 GINGIVAL PAIN 12 0.0015
182 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 1 0.0015
183 BLEPHARITIS 6 0.0015
184 ABSCESS NECK 1 0.0015
185 VULVOVAGINAL CANDIDIASIS 2 0.0015
186 EXTRAVASATION 6 0.0015
187 MENINGITIS VIRAL 2 0.0015
188 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 3 0.0014
189 ANAL HAEMORRHAGE 4 0.0014
190 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
191 ORGANISING PNEUMONIA 7 0.0014
192 IRON DEFICIENCY ANAEMIA 13 0.0014
193 ANTERIOR CHAMBER CELL 1 0.0014
194 METASTATIC NEOPLASM 6 0.0014
195 PERIODONTITIS 3 0.0014
196 HYPERTONIC BLADDER 4 0.0014
197 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
198 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
199 PNEUMONIA PNEUMOCOCCAL 2 0.0013
200 CONJUNCTIVITIS ALLERGIC 2 0.0013
201 IMPETIGO 2 0.0013
202 HYPERCAPNIA 4 0.0013
203 DISLOCATION OF VERTEBRA 3 0.0013
204 CARDIAC DISORDER 123 0.0013
205 OPHTHALMOPLEGIA 2 0.0013
206 FOREIGN BODY SENSATION IN EYES 8 0.0013
207 PULSE ABNORMAL 3 0.0012
208 IMMUNE-MEDIATED MYOCARDITIS 2 0.0012
209 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
210 CARTILAGE INJURY 3 0.0012
211 WALKING AID USER 8 0.0012
212 TOXIC SKIN ERUPTION 12 0.0012
213 ASTHMA 132 0.0012
214 PARTIAL SEIZURES 6 0.0011
215 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
216 RHEUMATIC FEVER 5 0.0011
217 BRAIN OEDEMA 14 0.0011
218 BLOOD PHOSPHORUS INCREASED 3 0.0011
219 ULCERATIVE KERATITIS 3 0.0011
220 VITREOUS HAEMORRHAGE 3 0.0011
221 BRAIN FOG 17 0.0011
222 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
223 CANDIDA INFECTION 18 0.0011
224 THYROID MASS 4 0.0010
225 HEPATIC MASS 2 0.0010
226 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
227 IMMUNE-MEDIATED HEPATIC DISORDER 2 0.0010
228 BICYTOPENIA 2 0.0010
229 ABDOMINAL TENDERNESS 5 0.0010
230 ENDOPHTHALMITIS 6 0.0010
231 THYROIDITIS 3 0.0010
232 EYE INJURY 3 0.0010
233 IRITIS 3 0.0010
234 ATRIAL THROMBOSIS 2 0.0010
235 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
236 HEPATITIS B REACTIVATION 3 0.0009
237 BILE DUCT STONE 3 0.0009
238 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
239 PEMPHIGOID 7 0.0009
240 LANGUAGE DISORDER 2 0.0009
241 VITAMIN D DEFICIENCY 9 0.0009
242 TENDON DISORDER 6 0.0009
243 NAIL DISORDER 8 0.0009
244 GRIP STRENGTH DECREASED 8 0.0009
245 PHYSICAL DISABILITY 4 0.0009
246 HYPOALBUMINAEMIA 7 0.0009
247 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
248 CHRONIC GASTRITIS 2 0.0009
249 GASTRIC POLYPS 2 0.0009
250 RETINAL DETACHMENT 8 0.0009
251 SENSORY LOSS 7 0.0009
252 NERVE COMPRESSION 8 0.0009
253 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
254 GASTRITIS EROSIVE 4 0.0009
255 BONE EROSION 3 0.0008
256 RETINAL HAEMORRHAGE 6 0.0008
257 TOOTHACHE 15 0.0008
258 C-REACTIVE PROTEIN INCREASED 30 0.0008
259 ADRENAL INSUFFICIENCY 10 0.0008
260 APATHY 12 0.0008
261 DEVICE INFUSION ISSUE 2 0.0008
262 HYPERNATRAEMIA 4 0.0008
263 TACHYARRHYTHMIA 2 0.0008
264 DERMATITIS EXFOLIATIVE 4 0.0008
265 SYSTEMIC CANDIDA 2 0.0008
266 DERMATITIS CONTACT 9 0.0008
267 FEEDING DISORDER 16 0.0008
268 BOWEL MOVEMENT IRREGULARITY 6 0.0008
269 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
270 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
271 LIPOMA 2 0.0008
272 TOOTH INFECTION 10 0.0008
273 HYPERPHAGIA 3 0.0008
274 SCHIZOPHRENIA 9 0.0007
275 BODY TEMPERATURE INCREASED 15 0.0007
276 ABSCESS ORAL 1 0.0007
277 IMMUNE-MEDIATED MYOSITIS 2 0.0007
278 LYMPHOEDEMA 5 0.0007
279 RASH MORBILLIFORM 2 0.0007
280 SKIN FISSURES 14 0.0007
281 EXTRASYSTOLES 5 0.0007
282 DRUG TOLERANCE DECREASED 2 0.0007
283 BODY TEMPERATURE DECREASED 7 0.0007
284 EJACULATION DISORDER 2 0.0007
285 CARDIAC FAILURE CHRONIC 3 0.0007
286 HYPERTENSION 149 0.0007
287 ABNORMAL SENSATION IN EYE 3 0.0007
288 RHEUMATOID FACTOR POSITIVE 4 0.0007
289 DYSPNOEA AT REST 2 0.0007
290 MADAROSIS 8 0.0007
291 DIVERTICULUM INTESTINAL 3 0.0007
292 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
293 HELICOBACTER INFECTION 7 0.0007
294 SYMPTOM RECURRENCE 4 0.0007
295 GENERAL SYMPTOM 5 0.0007
296 INTENTIONAL PRODUCT USE ISSUE 58 0.0007
297 NEPHROGENIC SYSTEMIC FIBROSIS 2 0.0007
298 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
299 PNEUMONIA BACTERIAL 6 0.0007
300 BREAST CANCER METASTATIC 7 0.0007
301 DEAFNESS 17 0.0006
302 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
303 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
304 CONJUNCTIVITIS 12 0.0006
305 RENAL FUNCTION TEST ABNORMAL 3 0.0006
306 MULTIPLE-DRUG RESISTANCE 2 0.0006
307 EYELIDS PRURITUS 2 0.0006
308 ASPIRATION 7 0.0006
309 NASAL DRYNESS 4 0.0006
310 BLINDNESS 26 0.0006
311 SINUS TACHYCARDIA 9 0.0006
312 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
313 IRIDOCYCLITIS 2 0.0006
314 INTRAOCULAR PRESSURE INCREASED 8 0.0006
315 PANCREATITIS ACUTE 14 0.0006
316 STUPOR 2 0.0006
317 HUMERUS FRACTURE 3 0.0006
318 ERUCTATION 12 0.0006
319 POSTURE ABNORMAL 2 0.0006
320 DEAFNESS NEUROSENSORY 2 0.0006
321 SPINAL COMPRESSION FRACTURE 5 0.0006
322 POST-TRAUMATIC STRESS DISORDER 4 0.0006
323 FREQUENT BOWEL MOVEMENTS 16 0.0006
324 TOXIC ENCEPHALOPATHY 3 0.0006
325 UVEITIS 8 0.0006
326 TOOTH ABSCESS 6 0.0006
327 EYE PAIN 33 0.0006
328 APLASIA PURE RED CELL 2 0.0006
329 HYPERBILIRUBINAEMIA 6 0.0006
330 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
331 MASS 8 0.0006
332 VISUAL ACUITY REDUCED 19 0.0006
333 CATARACT 34 0.0006
334 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
335 PAPULE 4 0.0006
336 JOINT DISLOCATION 6 0.0006
337 GENERALISED OEDEMA 7 0.0006
338 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
339 NEUTROPENIC SEPSIS 4 0.0006
340 ANGINA PECTORIS 16 0.0006
341 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4 0.0006
342 GRAFT VERSUS HOST DISEASE 4 0.0006
343 DERMATITIS BULLOUS 4 0.0006
344 FAECES SOFT 4 0.0005
345 SPONDYLITIS 2 0.0005
346 HEPATIC CYTOLYSIS 7 0.0005
347 HYPOMANIA 2 0.0005
348 GASTRIC ULCER HAEMORRHAGE 3 0.0005
349 FEELING DRUNK 4 0.0005
350 DUODENAL ULCER PERFORATION 4 0.0005
351 NEURODERMATITIS 2 0.0005
352 MULTIPLE USE OF SINGLE-USE PRODUCT 3 0.0005
353 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
354 PERIORBITAL SWELLING 3 0.0005
355 PAROSMIA 4 0.0005
356 AUTOIMMUNE THYROIDITIS 2 0.0005
357 HYPERSOMNIA 15 0.0005
358 ADVERSE EVENT 48 0.0005
359 GINGIVAL DISORDER 2 0.0005
360 BLOOD URIC ACID INCREASED 3 0.0005
361 RESTLESSNESS 19 0.0005
362 DELIRIUM 18 0.0005
363 PANIC DISORDER 2 0.0005
364 DIZZINESS POSTURAL 5 0.0005
365 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
366 ABDOMINAL WALL HAEMATOMA 1 0.0005
367 PHARYNGEAL SWELLING 5 0.0005
368 HEAD DISCOMFORT 9 0.0005
369 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
370 BLOOD ALBUMIN DECREASED 4 0.0005
371 SKIN PAPILLOMA 2 0.0005
372 HYPOKALAEMIA 23 0.0005
373 TYPE 1 DIABETES MELLITUS 3 0.0005
374 MYASTHENIA GRAVIS 4 0.0005
375 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
376 ABNORMAL FAECES 4 0.0005
377 ARTHRITIS BACTERIAL 2 0.0005
378 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
379 RIB FRACTURE 10 0.0005
380 LEG AMPUTATION 2 0.0005
381 PHOTOSENSITIVITY REACTION 8 0.0005
382 MUSCLE INJURY 4 0.0005
383 PHOTOPHOBIA 9 0.0005
384 WEIGHT FLUCTUATION 5 0.0005
385 PERICARDITIS 8 0.0005
386 LIP OEDEMA 2 0.0005
387 ANAEMIA MACROCYTIC 1 0.0005
388 SCAR 8 0.0005
389 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
390 BREAST CANCER STAGE III 3 0.0005
391 HAEMORRHOIDS 9 0.0005
392 MONOPLEGIA 2 0.0005
393 IMMOBILE 2 0.0005
394 ONYCHOMYCOSIS 2 0.0005
395 OSTEOARTHRITIS 19 0.0004
396 ILEUS PARALYTIC 2 0.0004
397 JOINT SWELLING 54 0.0004
398 MYOSITIS 4 0.0004
399 SUSPECTED OFF LABEL USE 2 0.0004
400 LUPUS-LIKE SYNDROME 4 0.0004
401 LIP DRY 4 0.0004
402 SYNOVIAL CYST 2 0.0004
403 MUSCLE TIGHTNESS 7 0.0004
404 ARTHRITIS INFECTIVE 2 0.0004
405 EYE SWELLING 16 0.0004
406 RIGHT VENTRICULAR FAILURE 3 0.0004
407 PLEURAL EFFUSION 26 0.0004
408 MOUTH ULCERATION 9 0.0004
409 DUODENAL ULCER 3 0.0004
410 PULMONARY TOXICITY 3 0.0004
411 LYMPHOPENIA 6 0.0004
412 BLOOD PROLACTIN INCREASED 2 0.0004
413 SEDATION 11 0.0004
414 CHOLECYSTITIS 5 0.0004
415 MUSCLE RIGIDITY 5 0.0004
416 HYPOVOLAEMIC SHOCK 2 0.0004
417 GLAUCOMA 8 0.0004
418 VISUAL FIELD DEFECT 3 0.0004
419 RASH VESICULAR 2 0.0004
420 FINGER DEFORMITY 2 0.0004
421 BURSITIS 5 0.0004
422 AUTOIMMUNE DISORDER 4 0.0004
423 HYPOPHOSPHATAEMIA 3 0.0004
424 OEDEMA 22 0.0004
425 HOSPITALISATION 62 0.0004
426 GLOSSODYNIA 9 0.0004
427 ECZEMA 21 0.0004
428 FLUID INTAKE REDUCED 2 0.0004
429 HYPOAESTHESIA ORAL 6 0.0004
430 ERYSIPELAS 2 0.0004
431 EYE DISORDER 13 0.0004
432 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
433 MUSCLE ATROPHY 5 0.0004
434 NEUTROPHIL COUNT INCREASED 4 0.0004
435 MUSCLE TWITCHING 9 0.0004
436 HIATUS HERNIA 5 0.0004
437 FAILURE TO THRIVE 2 0.0004
438 FOLLICULITIS 4 0.0004
439 RENAL CYST 3 0.0004
440 NYSTAGMUS 2 0.0004
441 SEPSIS 42 0.0004
442 MOOD SWINGS 12 0.0004
443 SCIATICA 6 0.0004
444 ATRIAL FLUTTER 3 0.0004
445 HEPATIC FUNCTION ABNORMAL 14 0.0004
446 SENSORY DISTURBANCE 6 0.0004
447 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
448 JOINT RANGE OF MOTION DECREASED 5 0.0004
449 RHINITIS 3 0.0004
450 INTERSTITIAL LUNG DISEASE 18 0.0004
451 PRESYNCOPE 9 0.0004
452 BLOOD URINE PRESENT 7 0.0004
453 CEREBRAL INFARCTION 9 0.0004
454 SKIN LACERATION 4 0.0004
455 MOOD ALTERED 10 0.0004
456 WOUND INFECTION 4 0.0004
457 FAECALOMA 2 0.0004
458 ASTHENOPIA 2 0.0004
459 CONTUSION 35 0.0004
460 MOBILITY DECREASED 26 0.0004
461 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
462 EAR PAIN 7 0.0004
463 CELLULITIS 18 0.0004
464 MACULAR OEDEMA 2 0.0004
465 OCULAR DISCOMFORT 4 0.0004
466 SKIN PLAQUE 3 0.0004
467 SWOLLEN TONGUE 11 0.0004
468 FACIAL PARALYSIS 3 0.0004
469 ANAPHYLACTIC SHOCK 9 0.0003
470 SKIN ULCER 9 0.0003
471 BALANCE DISORDER 30 0.0003
472 TASTE DISORDER 7 0.0003
473 INTESTINAL OBSTRUCTION 13 0.0003
474 STRESS CARDIOMYOPATHY 2 0.0003
475 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
476 HEART RATE DECREASED 12 0.0003
477 DRUG ERUPTION 6 0.0003
478 URINARY INCONTINENCE 10 0.0003
479 CATARACT OPERATION 2 0.0003
480 HAEMARTHROSIS 3 0.0003
481 HEARING IMPAIRED 2 0.0003
482 LIP SWELLING 11 0.0003
483 INGUINAL HERNIA 2 0.0003
484 EXOSTOSIS 3 0.0003
485 TENSION 2 0.0003
486 DISORIENTATION 13 0.0003
487 DEVICE RELATED INFECTION 5 0.0003
488 MEDICATION ERROR 18 0.0003
489 SCOLIOSIS 2 0.0003
490 AGRANULOCYTOSIS 6 0.0003
491 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
492 ILEUS 4 0.0003
493 DRY EYE 16 0.0003
494 MENINGIOMA 5 0.0003
495 PEMPHIGUS 4 0.0003
496 HYPONATRAEMIA 18 0.0003
497 HOT FLUSH 24 0.0003
498 MULTIPLE INJURIES 2 0.0003
499 BLEPHAROSPASM 2 0.0003
500 HYPOCALCAEMIA 6 0.0003
501 ABDOMINAL DISTENSION 33 0.0003
502 OCULAR HYPERAEMIA 15 0.0003
503 LIVER DISORDER 14 0.0003
504 OBESITY 5 0.0003
505 HEADACHE 195 0.0003
506 HYPERCHOLESTEROLAEMIA 3 0.0003
507 HYPERPROLACTINAEMIA 2 0.0003
508 ANGINA UNSTABLE 2 0.0003
509 PLATELET COUNT INCREASED 4 0.0003
510 HAND DEFORMITY 4 0.0003
511 JOINT STIFFNESS 8 0.0003
512 TINNITUS 14 0.0003
513 ORAL CANDIDIASIS 4 0.0003
514 INFUSION RELATED REACTION 20 0.0003
515 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
516 COAGULOPATHY 5 0.0003
517 DEVICE LEAKAGE 13 0.0003
518 PREGNANCY 6 0.0003
519 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
520 BLOOD UREA INCREASED 5 0.0003
521 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
522 COLITIS ISCHAEMIC 2 0.0003
523 EYELID PTOSIS 3 0.0003
524 DYSPEPSIA 29 0.0003
525 MOTOR DYSFUNCTION 3 0.0003
526 PRODUCTIVE COUGH 14 0.0003
527 EUPHORIC MOOD 3 0.0003
528 NEPHROTIC SYNDROME 2 0.0003
529 BLOOD PRESSURE FLUCTUATION 7 0.0003
530 MUSCULAR WEAKNESS 33 0.0003
531 POOR VENOUS ACCESS 3 0.0003
532 ENCEPHALITIS 2 0.0003
533 LARGE INTESTINE POLYP 2 0.0003
534 EYE DISCHARGE 3 0.0003
535 AORTIC STENOSIS 1 0.0003
536 ORTHOSTATIC HYPOTENSION 5 0.0003
537 OXYGEN SATURATION DECREASED 16 0.0003
538 BREAST PAIN 3 0.0003
539 PNEUMONIA ASPIRATION 7 0.0003
540 NIGHT SWEATS 9 0.0003
541 GOUT 5 0.0003
542 EYE IRRITATION 16 0.0003
543 SYNOVITIS 5 0.0003
544 PARAESTHESIA ORAL 4 0.0003
545 VISION BLURRED 38 0.0003
546 ANOSMIA 4 0.0003
547 OSTEOMYELITIS 5 0.0003
548 MELAENA 6 0.0003
549 TOOTH FRACTURE 3 0.0003
550 FEBRILE NEUTROPENIA 18 0.0003
551 DRY MOUTH 22 0.0003
552 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
553 PSYCHIATRIC SYMPTOM 2 0.0003
554 AMYLASE INCREASED 1 0.0003
555 FOOT DEFORMITY 3 0.0003
556 CARDIOMYOPATHY 4 0.0003
557 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
558 SYNCOPE 27 0.0003
559 DIPLOPIA 7 0.0003
560 MALNUTRITION 3 0.0003
561 ORAL PAIN 6 0.0003
562 EYE INFECTION 3 0.0003
563 TROPONIN INCREASED 2 0.0003
564 OEDEMA PERIPHERAL 32 0.0003
565 EPILEPSY 8 0.0003
566 PULMONARY FIBROSIS 5 0.0003
567 LYMPHOMA 4 0.0003
568 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
569 DELUSION 4 0.0003
570 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
571 EJECTION FRACTION DECREASED 4 0.0003
572 BASAL CELL CARCINOMA 4 0.0003
573 CHOKING 5 0.0003
574 DRUG-INDUCED LIVER INJURY 8 0.0003
575 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
576 BACTERAEMIA 3 0.0003
577 MYOCLONUS 3 0.0003
578 CEREBRAL HAEMORRHAGE 9 0.0003
579 SPINAL FRACTURE 5 0.0002
580 NOCTURIA 3 0.0002
581 FLATULENCE 14 0.0002
582 DISCOMFORT 15 0.0002
583 BACK PAIN 57 0.0002
584 THROAT IRRITATION 11 0.0002
585 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
586 CHOLELITHIASIS 8 0.0002
587 ANAPHYLACTOID REACTION 1 0.0002
588 DYSPNOEA 137 0.0002
589 AORTIC DISSECTION 1 0.0002
590 ACUTE CORONARY SYNDROME 2 0.0002
591 AGEUSIA 6 0.0002
592 DYSARTHRIA 9 0.0002
593 HAEMODIALYSIS 2 0.0002
594 CARDIAC FAILURE 19 0.0002
595 IRRITABLE BOWEL SYNDROME 5 0.0002
596 LIVER FUNCTION TEST INCREASED 5 0.0002
597 MUSCULOSKELETAL DISCOMFORT 4 0.0002
598 MYOPATHY 2 0.0002
599 STOMATITIS 14 0.0002
600 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
601 PRODUCT PRESCRIBING ISSUE 5 0.0002
602 SPEECH DISORDER 12 0.0002
603 ANHEDONIA 6 0.0002
604 PERIPHERAL SWELLING 35 0.0002
605 SARS-COV-2 TEST POSITIVE 3 0.0002
606 HYPOGLYCAEMIA 11 0.0002
607 LYMPHOCYTE COUNT DECREASED 4 0.0002
608 HERPES ZOSTER 13 0.0002
609 LIMB DISCOMFORT 7 0.0002
610 PURPURA 2 0.0002
611 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
612 TOOTH DISORDER 5 0.0002
613 FACIAL PAIN 2 0.0002
614 RASH PRURITIC 12 0.0002
615 SHOCK 5 0.0002
616 OVARIAN CANCER 2 0.0002
617 POLLAKIURIA 9 0.0002
618 ERYTHEMA MULTIFORME 2 0.0002
619 APPENDICITIS 2 0.0002
620 HEPATIC CIRRHOSIS 4 0.0002
621 BLINDNESS UNILATERAL 3 0.0002
622 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
623 PAIN IN JAW 6 0.0002
624 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
625 BLOOD PRESSURE DECREASED 14 0.0002
626 NERVOUSNESS 11 0.0002
627 GASTRIC ULCER 4 0.0002
628 PARAESTHESIA 33 0.0002
629 RASH ERYTHEMATOUS 10 0.0002
630 LETHARGY 12 0.0002
631 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
632 LOWER LIMB FRACTURE 4 0.0002
633 DEPRESSED MOOD 11 0.0002
634 HYPERTHYROIDISM 3 0.0002
635 ATELECTASIS 2 0.0002
636 PRESCRIBED OVERDOSE 4 0.0002
637 GASTROENTERITIS 3 0.0002
638 DYSSTASIA 6 0.0002
639 MUSCULOSKELETAL STIFFNESS 18 0.0002
640 PARKINSONISM 2 0.0002
641 ORAL HERPES 4 0.0002
642 SINUSITIS 21 0.0002
643 SWELLING 19 0.0002
644 OSTEONECROSIS OF JAW 5 0.0002
645 SALIVARY HYPERSECRETION 2 0.0002
646 SLEEP DISORDER 14 0.0002
647 DECREASED APPETITE 46 0.0002
648 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
649 PYREXIA 68 0.0002
650 SUBARACHNOID HAEMORRHAGE 2 0.0002
651 NEPHROLITHIASIS 9 0.0002
652 HIP ARTHROPLASTY 3 0.0002
653 LUNG NEOPLASM MALIGNANT 8 0.0002
654 OSTEOPOROSIS 8 0.0002
655 INFLAMMATION 10 0.0002
656 BLOOD CHOLESTEROL INCREASED 9 0.0002
657 ACUTE MYELOID LEUKAEMIA 3 0.0002
658 PULMONARY HYPERTENSION 4 0.0002
659 CONFUSIONAL STATE 31 0.0002
660 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
661 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
662 TRANSFUSION 2 0.0002
663 GASTRITIS 5 0.0002
664 KNEE ARTHROPLASTY 4 0.0002
665 SCRATCH 2 0.0002
666 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
667 BRADYCARDIA 10 0.0002
668 CYSTITIS 6 0.0002
669 MOVEMENT DISORDER 6 0.0002
670 ANAL FISSURE 1 0.0002
671 RECTAL HAEMORRHAGE 8 0.0002
672 BLOOD BILIRUBIN INCREASED 5 0.0002
673 ATRIAL FIBRILLATION 18 0.0002
674 FAECES DISCOLOURED 4 0.0002
675 IMPAIRED HEALING 6 0.0002
676 SKIN LESION 5 0.0002
677 DENTAL CARIES 2 0.0002
678 HYPOAESTHESIA 27 0.0002
679 HYPERTENSIVE CRISIS 2 0.0002
680 GAIT INABILITY 6 0.0002
681 DYSPHAGIA 17 0.0002
682 ABDOMINAL DISCOMFORT 30 0.0002
683 EYE PRURITUS 6 0.0002
684 PLATELET COUNT DECREASED 19 0.0002
685 TYPE 2 DIABETES MELLITUS 6 0.0002
686 GAIT DISTURBANCE 34 0.0002
687 HEART RATE IRREGULAR 4 0.0002
688 MITRAL VALVE INCOMPETENCE 2 0.0002
689 CIRCULATORY COLLAPSE 3 0.0002
690 MYOCARDIAL ISCHAEMIA 2 0.0002
691 HAEMOGLOBIN DECREASED 18 0.0002
692 MYOCARDITIS 2 0.0002
693 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
694 NIGHTMARE 6 0.0002
695 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
696 EYELID OEDEMA 2 0.0002
697 MUSCULOSKELETAL PAIN 9 0.0002
698 COVID-19 30 0.0002
699 DERMATITIS ATOPIC 9 0.0002
700 SEXUAL DYSFUNCTION 2 0.0002
701 ASCITES 5 0.0002
702 ABDOMINAL PAIN UPPER 35 0.0002
703 CONSTIPATION 37 0.0002
704 ACUTE MYOCARDIAL INFARCTION 5 0.0002
705 ATAXIA 2 0.0002
706 MACULAR DEGENERATION 2 0.0002
707 RENAL IMPAIRMENT 14 0.0002
708 DIABETIC KETOACIDOSIS 4 0.0002
709 APHASIA 5 0.0002
710 CYTOPENIA 2 0.0002
711 ABDOMINAL PAIN 38 0.0002
712 LUNG DISORDER 8 0.0002
713 DYSURIA 6 0.0002
714 ALOPECIA 32 0.0002
715 CARDIOMEGALY 2 0.0002
716 PHARYNGITIS 2 0.0002
717 WEIGHT DECREASED 45 0.0002
718 HEPATIC STEATOSIS 3 0.0002
719 PANCYTOPENIA 9 0.0002
720 INJECTION SITE REACTION 11 0.0002
721 DERMATITIS ALLERGIC 2 0.0002
722 MYALGIA 27 0.0002
723 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
724 HEAD INJURY 5 0.0002
725 PROTEINURIA 3 0.0002
726 ACUTE KIDNEY INJURY 24 0.0002
727 DIARRHOEA 101 0.0002
728 MYDRIASIS 2 0.0002
729 ANOREXIA 2 0.0002
730 INSOMNIA 41 0.0002
731 RESPIRATORY TRACT INFECTION 4 0.0002
732 VISUAL IMPAIRMENT 19 0.0002
733 MUCOSAL INFLAMMATION 4 0.0002
734 URINARY TRACT INFECTION 26 0.0002
735 SKIN DISCOLOURATION 7 0.0002
736 STAPHYLOCOCCAL INFECTION 5 0.0002
737 SINUS DISORDER 3 0.0002
738 HAEMATOCRIT DECREASED 3 0.0002
739 BLOOD PRESSURE ABNORMAL 3 0.0002
740 MALAISE 66 0.0002
741 FALL 50 0.0002
742 EYE HAEMORRHAGE 2 0.0001
743 URINARY RETENTION 5 0.0001
744 PNEUMONIA 48 0.0001
745 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
746 DYSKINESIA 6 0.0001
747 NEUTROPHIL COUNT DECREASED 6 0.0001
748 PNEUMONITIS 4 0.0001
749 ABNORMAL LOSS OF WEIGHT 1 0.0001
750 CHEST DISCOMFORT 15 0.0001
751 GINGIVAL BLEEDING 2 0.0001
752 BLOOD GLUCOSE DECREASED 7 0.0001
753 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
754 ARTHRALGIA 60 0.0001
755 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
756 ORAL DISCOMFORT 2 0.0001
757 DERMATITIS 3 0.0001
758 RASH MACULAR 5 0.0001
759 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
760 DIZZINESS 70 0.0001
761 RED BLOOD CELL COUNT DECREASED 4 0.0001
762 ARTHRITIS 11 0.0001
763 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
764 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
765 HYPERGLYCAEMIA 5 0.0001
766 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
767 PALPITATIONS 16 0.0001
768 ANAEMIA 26 0.0001
769 VOMITING 64 0.0001
770 STEVENS-JOHNSON SYNDROME 3 0.0001
771 RASH MACULO-PAPULAR 3 0.0001
772 COLITIS ULCERATIVE 6 0.0001
773 HAEMORRHAGE 14 0.0001
774 RASH PAPULAR 3 0.0001
775 RESPIRATORY DISORDER 4 0.0001
776 EPISTAXIS 10 0.0001
777 IRRITABILITY 8 0.0001
778 TREATMENT FAILURE 11 0.0001
779 RHEUMATOID ARTHRITIS 15 0.0001
780 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
781 AORTIC ANEURYSM 1 0.0001
782 PERICARDIAL EFFUSION 3 0.0001
783 MUSCULOSKELETAL CHEST PAIN 2 0.0001
784 FEMUR FRACTURE 4 0.0001
785 RASH 56 0.0001
786 OFF LABEL USE 111 0.0001
787 ARRHYTHMIA 6 0.0001
788 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
789 NEUROPATHY PERIPHERAL 12 0.0001
790 ARTHROPATHY 7 0.0001
791 HALLUCINATION, AUDITORY 2 0.0001
792 ABSCESS 2 0.0001
793 ASTHENIA 47 0.0001
794 NAUSEA 98 0.0001
795 BLOOD CREATININE INCREASED 8 0.0001
796 LIVER INJURY 3 0.0001
797 METASTASES TO BONE 2 0.0001
798 FEELING ABNORMAL 29 0.0001
799 DRUG LEVEL INCREASED 2 0.0001
800 MUSCLE SPASMS 22 0.0001
801 ROAD TRAFFIC ACCIDENT 5 0.0001
802 CHILLS 14 0.0001
803 CHEST PAIN 22 0.0001
804 DEPRESSION 27 0.0001
805 ABDOMINAL PAIN LOWER 3 0.0001
806 DISEASE PROGRESSION 14 0.0001
807 INFECTION 17 0.0001
808 HEPATIC ENZYME INCREASED 8 0.0001
809 HYPOPHAGIA 3 0.0001
810 ERECTILE DYSFUNCTION 3 0.0001
811 HAEMATURIA 4 0.0001
812 ANURIA 1 0.0001
813 RASH GENERALISED 3 0.0001
814 PAIN IN EXTREMITY 34 0.0001
815 ILL-DEFINED DISORDER 7 0.0001
816 FEELING HOT 7 0.0001
817 HYPERKALAEMIA 4 0.0001
818 METASTASES TO LIVER 2 0.0001
819 COLD SWEAT 2 0.0001
820 URTICARIA 19 0.0001
821 ANGIOEDEMA 5 0.0001
822 EAR INFECTION 3 0.0001
823 DEHYDRATION 15 0.0001
824 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
825 PAIN OF SKIN 3 0.0001
826 THERAPY NON-RESPONDER 5 0.0001
827 ANAL INCONTINENCE 1 0.0001
828 HYPOTENSION 22 0.0001
829 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
830 RESPIRATORY DISTRESS 3 0.0001
831 PROCEDURAL PAIN 3 0.0001
832 BRONCHITIS 8 0.0001
833 FEELING COLD 3 0.0001
834 NECK PAIN 6 0.0001
835 DEMENTIA 3 0.0001
836 WOUND 3 0.0001
837 BACTERIAL INFECTION 2 0.0001
838 BLISTER 6 0.0001
839 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
840 PRURITUS 41 0.0001
841 SKIN EXFOLIATION 9 0.0001
842 ABORTION INDUCED 1 0.0001
843 FRACTURE 2 0.0001
844 COLITIS 4 0.0001
845 ANXIETY 30 0.0001
846 PAIN 64 0.0001
847 FATIGUE 81 0.0001
848 ACUTE RESPIRATORY FAILURE 2 0.0001
849 LIVER FUNCTION TEST ABNORMAL 3 0.0001
850 PLASMA CELL MYELOMA 4 0.0001
851 HYPERSENSITIVITY 19 0.0001
852 LABORATORY TEST ABNORMAL 3 0.0001
853 DISABILITY 2 0.0001
854 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
855 BLOOD GLUCOSE INCREASED 19 0.0001
856 UPPER LIMB FRACTURE 2 0.0001
857 CEREBROVASCULAR ACCIDENT 17 0.0001
858 PRESCRIBED UNDERDOSE 2 0.0001
859 CYTOKINE RELEASE SYNDROME 2 0.0001
860 HEPATIC FAILURE 3 0.0001
861 LACRIMATION INCREASED 3 0.0001
862 PSORIATIC ARTHROPATHY 4 0.0001
863 FLUID RETENTION 5 0.0001
864 WEIGHT INCREASED 22 0.0001
865 EMOTIONAL DISORDER 3 0.0001
866 COUGH 27 0.0001
867 RESPIRATORY FAILURE 7 0.0001
868 NEUTROPENIA 13 0.0001
869 HALLUCINATION, VISUAL 2 0.0001
870 METABOLIC ACIDOSIS 3 0.0001
871 LACTIC ACIDOSIS 3 0.0001
872 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
873 SWELLING FACE 6 0.0001
874 SEPTIC SHOCK 4 0.0001
875 DIABETES MELLITUS 7 0.0001
876 TREMOR 15 0.0001
877 VIRAL INFECTION 3 0.0001
878 TRANSAMINASES INCREASED 2 0.0001
879 GASTROINTESTINAL DISORDER 8 0.0001
880 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
881 TOXICITY TO VARIOUS AGENTS 15 0.0001
882 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
883 CONDITION AGGRAVATED 27 0.0001
884 GASTRIC DISORDER 3 0.0001
885 MEMORY IMPAIRMENT 12 0.0001
886 NASOPHARYNGITIS 16 0.0001
887 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
888 DYSPHONIA 5 0.0001
889 INJURY 6 0.0001
890 BLOOD PRESSURE INCREASED 13 0.0001
891 PRODUCT DOSE OMISSION ISSUE 25 0.0001
892 DISEASE RECURRENCE 4 0.0001
893 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
894 CRYING 3 0.0001
895 THERAPEUTIC RESPONSE DECREASED 5 0.0001
896 DRY SKIN 11 0.0001
897 VERTIGO 5 0.0001
898 DRUG INTERACTION 13 0.0001
899 AGITATION 6 0.0001
900 EXTRAPYRAMIDAL DISORDER 2 0.0001
901 LEUKOPENIA 4 0.0001
902 SOMNOLENCE 16 0.0001
903 HAEMATEMESIS 2 0.0001
904 ADVERSE DRUG REACTION 7 0.0001
905 ERYTHEMA 16 0.0001
906 RHINORRHOEA 5 0.0001
907 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
908 PALLOR 2 0.0001
909 MIGRAINE 7 0.0001
910 CARDIAC ARREST 6 0.0001
911 RESPIRATORY ARREST 2 0.0001
912 MENTAL STATUS CHANGES 2 0.0001
913 HAEMOPTYSIS 2 0.0001
914 TARDIVE DYSKINESIA 2 0.0001
915 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
916 INCORRECT DOSE ADMINISTERED 16 0.0001
917 HYPERHIDROSIS 9 0.0001
918 PANCREATIC CARCINOMA 2 0.0001
919 PRODUCT USE ISSUE 13 0.0001
920 PSORIASIS 9 0.0001
921 SURGERY 4 0.0001
922 TACHYCARDIA 6 0.0001
923 CORONARY ARTERY DISEASE 2 0.0001
924 OROPHARYNGEAL PAIN 6 0.0001
925 NERVOUS SYSTEM DISORDER 2 0.0001
926 PULMONARY EMBOLISM 6 0.0001
927 THROMBOCYTOPENIA 7 0.0001
928 LOSS OF CONSCIOUSNESS 8 0.0001
929 AMNESIA 4 0.0001
930 OSTEONECROSIS 2 0.0001
931 HEART RATE INCREASED 6 0.0001
932 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
933 OVERDOSE 13 0.0001
934 FUNGAL INFECTION 2 0.0001
935 SKIN DISORDER 2 0.0001
936 AGGRESSION 3 0.0001
937 INJECTION SITE PAIN 18 0.0001
938 ILLNESS 6 0.0001
939 PANCREATITIS 3 0.0001
940 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
941 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
942 DRUG EFFECT DECREASED 3 0.0001
943 MYELOSUPPRESSION 2 0.0001
944 UNDERDOSE 4 0.0001
945 SUICIDAL IDEATION 5 0.0001
946 ANAPHYLACTIC REACTION 3 0.0001
947 DYSPNOEA EXERTIONAL 2 0.0001
948 HALLUCINATION 4 0.0001
949 INJECTION SITE SWELLING 4 0.0001
950 DRUG INTOLERANCE 5 0.0001
951 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
952 ABNORMAL BEHAVIOUR 2 0.0001
953 INFLUENZA LIKE ILLNESS 4 0.0000
954 INJECTION SITE ERYTHEMA 6 0.0000
955 EXPOSURE DURING PREGNANCY 3 0.0000
956 RHABDOMYOLYSIS 2 0.0000
957 WITHDRAWAL SYNDROME 2 0.0000
958 DEVICE DISLOCATION 2 0.0000
959 MENTAL DISORDER 2 0.0000
960 INTENTIONAL PRODUCT MISUSE 4 0.0000
961 INFLUENZA 5 0.0000
962 MULTIPLE SCLEROSIS 2 0.0000
963 FLUSHING 4 0.0000
964 INJECTION SITE BRUISING 3 0.0000
965 CARDIAC FAILURE CONGESTIVE 3 0.0000
966 DISTURBANCE IN ATTENTION 2 0.0000
967 ABNORMAL DREAMS 1 0.0000
968 MYOCARDIAL INFARCTION 6 0.0000
969 PRODUCT STORAGE ERROR 3 0.0000
970 BONE PAIN 2 0.0000
971 EMOTIONAL DISTRESS 4 0.0000
972 DEATH 27 0.0000
973 DRUG INEFFECTIVE 41 0.0000
974 DEEP VEIN THROMBOSIS 2 0.0000
975 RENAL FAILURE 4 0.0000
976 NEOPLASM MALIGNANT 2 0.0000
977 ACCIDENTAL OVERDOSE 1 0.0000
978 INJECTION SITE HAEMORRHAGE 2 0.0000
979 PROSTATE CANCER 2 0.0000
980 THROMBOSIS 2 0.0000
981 NO ADVERSE EVENT 4 0.0000
982 BREAST CANCER 2 0.0000
983 SEIZURE 2 0.0000
984 PRODUCT QUALITY ISSUE 2 0.0000
985 ACNE 1 0.0000
986 DRUG DEPENDENCE 2 0.0000
987 DRUG DOSE OMISSION 2 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000